Clinical trial

A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease

NCT02982187

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-12-30

PhasePHASE4

Study timeline

Study start (actual)2016-12-30Date precision: day

Registry last updated2019-10-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

Placebo ELLIPTADEVICE

Placebo DISKUSDEVICE

Placebo TURBUHALERDEVICE

Placebo HANDIHALERDEVICE

PQ1OTHER

PQ2OTHER

PQ3OTHER

PQ4OTHER

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

LondonUnited Kingdom2 RotterdamNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02982187 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.